Stocks in play: Kalytera Therapeutics, Inc.
Has elected to issue 2,923,491 common shares of the Company to The Salzman Group in payment of invoices issued under the payments agreement with The Salzman Group. Kalytera Therapeutics, Inc. shares V.KALY are trading up $0.005 at $0.16.